Found: 37
Select item for more details and to access through your institution.
Relationship of the Calcitonin Gene‐Related Peptide Monoclonal Antibody Galcanezumab Pharmacokinetics and Capsaicin‐Induced Dermal Blood Flow in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 5, p. 440, doi. 10.1002/cpdd.929
- By:
- Publication type:
- Article
Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 9, p. 5833, doi. 10.1002/alz.13908
- By:
- Publication type:
- Article
Donanemab in Early Symptomatic Alzheimer's Disease: Efficacy and Safety in TRAILBLAZER‐ALZ 2, a Phase 3 Randomized Clinical Trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082733
- By:
- Publication type:
- Article
TRAILBLAZER‐ALZ 4: Directly comparing donanemab to aducanumab on amyloid lowering in early, symptomatic Alzheimer's disease ‐ Results from 12‐months.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082529
- By:
- Publication type:
- Article
Harmonization of tau‐PET in Alzheimer's disease: comparison of methods to derive CenTauR units for [<sup>18</sup>F]RO948, [<sup>18</sup>F]Flortaucipir, and [<sup>18</sup>F]MK‐6240.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080421
- By:
- Publication type:
- Article
Amyloid re‐accumulation after donanemab treatment: summary from 3 interventional trials.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078175
- By:
- Publication type:
- Article
Harmonization of tau‐PET in Alzheimer's disease: comparison of methods to derive CenTauR units for [18F]RO948, [18F]Flortaucipir, and [18F]MK‐6240.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.082006
- By:
- Publication type:
- Article
Prognostic value of regional tau PET measures in Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.067677
- By:
- Publication type:
- Article
Brain target occupancy of LY3372689, an inhibitor of the O‐GlcNAcase (OGA) enzyme, following administration of single and multiple doses to healthy volunteers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057774
- By:
- Publication type:
- Article
TRAILBLAZER‐ALZ Study: Dynamics of amyloid reduction after donanemab treatment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057492
- By:
- Publication type:
- Article
Methods and future directions for evaluation of Tau PET signal.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.049678
- By:
- Publication type:
- Article
Network diffusion model enhances predictions of future tau‐PET burden in Alzheimer's patients: Development of new models and analysis methods: Novel imaging analysis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.039480
- By:
- Publication type:
- Article
P3‐026: IMPLEMENTATION OF DUAL‐PHASE FLORBETAPIR PET IN THE MULTICENTER PHASE 2 NAVIGATE‐AD CLINICAL TRIAL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P935, doi. 10.1016/j.jalz.2019.06.3052
- By:
- Publication type:
- Article
In Vivo Imaging of Tau Pathology Using Magnetic Resonance Imaging Textural Analysis.
- Published in:
- Frontiers in Neuroscience, 2017, p. 1, doi. 10.3389/fnins.2017.00599
- By:
- Publication type:
- Article
INVESTIGATING GLYMPHATIC FUNCTION DURING EARLY TAU PATHOLOGY USING DYNAMIC CONTRAST-ENHANCED MRI.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P393, doi. 10.1016/j.jalz.2017.06.370
- By:
- Publication type:
- Article
INVESTIGATING GLYMPHATIC FUNCTION DURING EARLY TAU PATHOLOGY USING DYNAMIC CONTRAST-ENHANCED MRI.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P24, doi. 10.1016/j.jalz.2017.06.2296
- By:
- Publication type:
- Article
FMRI OF VISUAL STIMULI IN A TAU MODEL OF ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1275, doi. 10.1016/j.jalz.2017.06.1913
- By:
- Publication type:
- Article
FMRI OF VISUAL STIMULI IN A TAU MODEL OF ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P142, doi. 10.1016/j.jalz.2017.06.2568
- By:
- Publication type:
- Article
A multiscale MRI approach to investigate novel drug treatment strategies in mouse models of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P106, doi. 10.1016/j.jalz.2015.06.181
- By:
- Publication type:
- Article
Imaging the efficacy of microtubule stabilizing agent epothilone d in the rtg4510 mouse model of tauopathy.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P348, doi. 10.1016/j.jalz.2015.06.182
- By:
- Publication type:
- Article
Glymphatic clearance impaired in a mouse model of tauopathy: Captured using contrast-enhanced MRI.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P544, doi. 10.1016/j.jalz.2015.06.688
- By:
- Publication type:
- Article
Glymphatic clearance impaired in a mouse model of tauopathy: Captured using contrast-enhanced MRI.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P107, doi. 10.1016/j.jalz.2015.06.183
- By:
- Publication type:
- Article
A multi-scale MRI approach to investigate novel drug treatment strategies in mouse models of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P226, doi. 10.1016/j.jalz.2015.07.255
- By:
- Publication type:
- Article
Imaging the efficacy of microtubule stabilizing agent epothilone d in the rtg4510 mouse model of tauopathy.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P107, doi. 10.1016/j.jalz.2015.06.182
- By:
- Publication type:
- Article
Glucose Metabolic Trapping in Mouse Arteries: Nonradioactive Assay of Atherosclerotic Plaque Inflammation Applicable to Drug Discovery.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0050349
- By:
- Publication type:
- Article
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 6, p. 512, doi. 10.1001/jama.2023.13239
- By:
- Publication type:
- Article
The Social Triad Model: Considering the Deployer in a Novel Approach to Trust in Human–Robot Interaction.
- Published in:
- International Journal of Social Robotics, 2024, v. 16, n. 6, p. 1405, doi. 10.1007/s12369-023-01048-3
- By:
- Publication type:
- Article
Increased cerebral vascular reactivity in the tau expressing rTg4510 mouse: evidence against the role of tau pathology to impair vascular health in Alzheimer's disease.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2015, v. 35, n. 3, p. 359, doi. 10.1038/jcbfm.2014.224
- By:
- Publication type:
- Article
Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 12, p. 1250, doi. 10.1001/jamaneurol.2022.3392
- By:
- Publication type:
- Article
PET quantification of brain O-GlcNAcase with [18F]LSN3316612 in healthy human volunteers.
- Published in:
- EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-0616-4
- By:
- Publication type:
- Article
Comparison of In Vivo and Ex Vivo MRI for the Detection of Structural Abnormalities in a Mouse Model of Tauopathy.
- Published in:
- Frontiers in Neuroinformatics, 2017, v. 11, p. 1, doi. 10.3389/fninf.2017.00020
- By:
- Publication type:
- Article
Neurorehabilitation robotics: how much control should therapists have?
- Published in:
- Frontiers in Human Neuroscience, 2023, p. 1, doi. 10.3389/fnhum.2023.1179418
- By:
- Publication type:
- Article
A review of the flortaucipir literature for positron emission tomography imaging of tau neurofibrillary tangles.
- Published in:
- Brain Communications, 2024, v. 6, n. 1, p. 1, doi. 10.1093/braincomms/fcad305
- By:
- Publication type:
- Article
Tau as a diagnostic instrument in clinical trials to predict amyloid in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2023, v. 9, n. 3, p. 1, doi. 10.1002/trc2.12415
- By:
- Publication type:
- Article
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00740
- By:
- Publication type:
- Article
Study the Longitudinal in vivo and Cross-Sectional ex vivo Brain Volume Difference for Disease Progression and Treatment Effect on Mouse Model of Tauopathy Using Automated MRI Structural Parcellation.
- Published in:
- Frontiers in Neuroscience, 2019, p. N.PAG, doi. 10.3389/fnins.2019.00011
- By:
- Publication type:
- Article
An Overview of Verification and Validation Challenges for Inspection Robots.
- Published in:
- Robotics, 2021, v. 10, n. 2, p. 67, doi. 10.3390/robotics10020067
- By:
- Publication type:
- Article